4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-115595
Director sold 36,684 shares at an average $35.29 ($1,294,437)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2024-10-16 | Sale 10b5-1 | −23,671 | $35.35 | $836,770 | 99,652 | I |
| Kersten Dirk Director | 2024-10-17 | Sale 10b5-1 | −13,013 | $35.17 | $457,667 | 86,639 | I |
| Open-market sales · 36,684 sh · avg $35.29 · $1,294,437 | |||||||
Loading xslF345X05/ownership.xml…